US 9814777
Targeting lipids
granted A61KA61K31/70A61K31/7004
Quick answer
US patent 9814777 (Targeting lipids) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/70, A61K31/7004, A61K31/7052, A61K31/7088